Difference between revisions of "Henson SM, et al. Curr. Opin. Immunol. (2012) cited as Ref 719 in DOI: 10.1038/s41392-020-0110-5 (Q9982)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2012, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Curr. Opin. Immunol., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Curr. Opin. Immunol. | ||
| Property / Published In Name String: Curr. Opin. Immunol. / rank | |||
| + | Normal rank | ||
Revision as of 21:10, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Henson SM, et al. Curr. Opin. Immunol. (2012) cited as Ref 719 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Henson SM
0 references
Riddell NE
0 references
Akbar AN
0 references
2012
0 references
Curr. Opin. Immunol.
0 references
